Church & Dwight Reports Q2 2022 Results
Church & Dwight Co., Inc. (NYSE: CHD) reported a 4.2% increase in net sales for Q2 2022, reaching $1,325.1 million. Domestic sales grew by 4.7% while international sales rose by 1.6%. The company's organic sales improved by 3.4%, mainly due to price increases. However, EPS was flat at $0.76 compared to the previous year, affected by a 12.6% decline year-over-year. Looking ahead, the company expects 2022 net sales growth to range between 4% to 5% with organic sales anticipated between 3% to 4%. Cash from operations is projected at $900 million.
- Net sales increased 4.2% to $1,325.1 million in Q2 2022.
- Domestic sales grew by 4.7%, showing strong consumer demand.
- Organic sales increased 3.4%, driven by positive pricing actions.
- The company's EPS of $0.76 exceeded expectations of $0.70.
- Acquisitions of ZICAM and THERABREATH are performing well with double-digit growth.
- EPS flat year-over-year, with a 12.6% decline from 2021 reported EPS.
- Gross margin contracted by 220 bps due to rising commodity costs.
- Expected additional $50 million in cost inflation for 2022.
- Anticipated gross margin decrease due to inflation outpacing pricing.
2022 Second Quarter Results
-
Net Sales +4.2% : Domestic +4.7% , Int’l +1.6 %, SPD +6.3% -
Organic sales +
3.4% : Domestic +2.4% , Int’l +6.5% , SPD +6.3% -
EPS
, flat to prior year Adjusted EPS ¹$0.76
2022 Full Year Outlook
-
Net Sales growth +4% to +5% ; Organic Sales +3% to +4% ¹ -
Reported EPS -
9% , Adjusted EPS flat¹ -
Cash from operations
~ $900 million
Second quarter 2022 EPS was
“We believe the recent improvement in fill rates (Q2
“Our International business had organic sales growth of
“Gross margin contracted 220 bps reflecting higher commodities and third-party manufacturing costs. We now expect an additional
“Our recent acquisitions are performing well, with both ZICAM™ and THERABREATH™ experiencing double-digit consumption growth, increasing distribution, and gaining share. The THERABREATH™ acquisition is now fully integrated. We continue to pursue acquisitions that meet our strict criteria.”
Second Quarter Review
Consumer Domestic net sales were
Specialty Products net sales were
Gross margin decreased 220 basis points to
Marketing expense was
Selling, general, and administrative expense (SG&A)was
Income from Operations was
Other Expense of
The effective tax rate increased to
Operating Cash Flow
For the first six months of 2022, cash from operating activities was
Capital expenditures for the first six months were
On
2022 New Products
“We are entering a new segment with ARM & HAMMER™ Baby Hypoallergenic Detergent, which has zero preservatives, phosphates or dyes. It is
“The TROJAN™ brand is launching two new condoms, TROJAN™ ULTRAFIT ™, and TROJAN™ BARESKIN RAW™.
“We are expanding ARM & HAMMER™ Forever Fresh Clumping Cat Litter, leveraging the growing trend of Essential Oils in providing long lasting odor control and freshness.
“The VITAFUSION™ brand has launched 2 in 1 Bi-Layer Gummies, which brings two benefits to the consumer. The ZICAM™ brand is launching their first immune supplement gummies, which provides for daily and nighttime immune support with Zinc + Vitamins C&D.
“THERABREATH™ launched a Whitening Rinse to complement the existing line and address a growing need in the category.”
Outlook for 2022
“We continue to anticipate full year reported gross margin to be down versus 2021, as we expect inflation to outpace pricing and productivity. Marketing spend is now expected to be lower in 2022 driven by the lower spend in the first half of the year that was driven by lower fill levels. In the second half, marketing dollar spend is expected to be significantly higher than the first half.
“Reflecting the impact of both higher cost inflation and a negative foreign currency impact of approximately
“We expect second half EPS to be flat to 2021. In Q3, we expect reported sales growth of approximately 2
“In Q4, we expect higher organic growth and significant EPS growth due to accelerated trade down to our value portfolio, recovery of fill rates in personal care and promotional support closer to pre COVID levels. Prior year Q4 was also burdened by onetime charges and investments.”
¹ See non-GAAP reporting reconciliations included at the end of this release. Except for organic sales, the Company’s 2022 results and outlook do not include adjustments from reported amounts.
For more information, see the
https://churchdwight.com/responsibility/
This press release contains forward-looking statements, including, among others, statements relating to net sales and earnings growth; the impact of the COVID-19 pandemic and the Company’s response; gross margin changes; trade, marketing, and SG&A spending; sufficiency of cash flows from operations; earnings per share; cost savings programs; recessionary conditions; consumer demand and spending; the effects of competition; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the impact of acquisitions (including earn-outs); and capital expenditures. Other forward-looking statements in this release may be identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,” “to be,” “to make” or other comparable terms. These statements represent the intentions, plans, expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that could cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); including those relating to the outbreak of contagious diseases; other impacts of the COVID-19 pandemic and its impact on the Company’s operations, customers, suppliers, employees, and other constituents, and market volatility and impact on the economy (including causing recessionary conditions), resulting from global, nationwide or local or regional outbreaks or increases in infections, new variants, and the risk that the Company will not be able to successfully execute its response plans with respect to the pandemic or localized outbreaks and the corresponding uncertainty; the impact of regulatory changes or policies associated with the COVID-19 pandemic, including continuing or renewed shutdowns of retail and other businesses in various jurisdictions; the impact on the global economy of the military conflict between
For a description of additional factors that could cause actual results to differ materially from the forward-looking statements, please see Item 1A, “Risk Factors” in the Company’s annual report on Form 10-K and quarterly reports on Form 10-Q. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the
This press release also contains non-GAAP financial information. Management uses this information in its internal analysis of results and believes that this information may be informative to investors in gauging the quality of the Company’s financial performance, identifying trends in its results and providing meaningful period-to-period comparisons. The Company has included reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated in accordance with GAAP. See the end of this press release for these reconciliations. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read in connection with the Company’s financial statements presented in accordance with GAAP.
|
||||||||||||||||
Condensed Consolidated Statements of Income (Unaudited) |
||||||||||||||||
|
|
Three Months Ended |
|
|
Six Months Ended |
|
||||||||||
(In millions, except per share data) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
$ |
1,325.1 |
|
|
$ |
1,271.1 |
|
|
$ |
2,622.3 |
|
|
$ |
2,510.0 |
|
Cost of sales |
|
|
779.8 |
|
|
|
718.9 |
|
|
|
1,524.5 |
|
|
|
1,406.9 |
|
Gross Profit |
|
|
545.3 |
|
|
|
552.2 |
|
|
|
1,097.8 |
|
|
|
1,103.1 |
|
Marketing expenses |
|
|
102.9 |
|
|
|
117.0 |
|
|
|
204.8 |
|
|
|
215.7 |
|
Selling, general and administrative expenses |
|
|
180.8 |
|
|
|
136.5 |
|
|
|
350.7 |
|
|
|
286.1 |
|
Income from Operations |
|
|
261.6 |
|
|
|
298.7 |
|
|
|
542.3 |
|
|
|
601.3 |
|
Equity in earnings of affiliates |
|
|
3.9 |
|
|
|
2.8 |
|
|
|
6.3 |
|
|
|
5.4 |
|
Other income (expense), net |
|
|
(19.0 |
) |
|
|
(14.2 |
) |
|
|
(35.9 |
) |
|
|
(28.4 |
) |
Income before Income Taxes |
|
|
246.5 |
|
|
|
287.3 |
|
|
|
512.7 |
|
|
|
578.3 |
|
Income taxes |
|
|
59.4 |
|
|
|
69.0 |
|
|
|
121.2 |
|
|
|
139.3 |
|
Net Income |
|
$ |
187.1 |
|
|
$ |
218.3 |
|
|
$ |
391.5 |
|
|
$ |
439.0 |
|
Net Income per share - Basic |
|
$ |
0.77 |
|
|
$ |
0.89 |
|
|
$ |
1.61 |
|
|
$ |
1.79 |
|
Net Income per share - Diluted |
|
$ |
0.76 |
|
|
$ |
0.87 |
|
|
$ |
1.59 |
|
|
$ |
1.76 |
|
Dividends per share |
|
$ |
0.26 |
|
|
$ |
0.25 |
|
|
$ |
0.53 |
|
|
$ |
0.50 |
|
Weighted average shares outstanding - Basic |
|
|
242.6 |
|
|
|
245.2 |
|
|
|
242.6 |
|
|
|
245.2 |
|
Weighted average shares outstanding - Diluted |
|
|
246.4 |
|
|
|
250.0 |
|
|
|
246.5 |
|
|
|
249.9 |
|
|
||||||||
Condensed Consolidated Balance Sheets (Unaudited) |
||||||||
(Dollars in millions) |
|
|
|
|
|
|
||
Assets |
|
|
|
|
|
|
||
Current Assets |
|
|
|
|
|
|
||
Cash and Cash Equivalents |
|
$ |
639.7 |
|
|
$ |
240.6 |
|
Accounts Receivable |
|
|
405.8 |
|
|
|
405.5 |
|
Inventories |
|
|
663.0 |
|
|
|
535.4 |
|
Other Current Assets |
|
|
42.2 |
|
|
|
51.9 |
|
Total Current Assets |
|
|
1,750.7 |
|
|
|
1,233.4 |
|
Property, Plant and Equipment (Net) |
|
|
660.6 |
|
|
|
652.7 |
|
|
|
|
12.2 |
|
|
|
9.1 |
|
|
|
|
3,434.6 |
|
|
|
3,494.3 |
|
|
|
|
2,270.7 |
|
|
|
2,274.5 |
|
Other Long-Term Assets |
|
|
316.0 |
|
|
|
332.5 |
|
Total Assets |
|
$ |
8,444.8 |
|
|
$ |
7,996.5 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
||
Short-Term Debt |
|
$ |
3.3 |
|
|
$ |
252.8 |
|
Current portion of Long-Term debt |
|
|
699.9 |
|
|
|
699.4 |
|
Other Current Liabilities |
|
|
1,023.6 |
|
|
|
1,123.0 |
|
Total Current Liabilities |
|
|
1,726.8 |
|
|
|
2,075.2 |
|
Long-Term Debt |
|
|
2,103.9 |
|
|
|
1,610.7 |
|
Other Long-Term Liabilities |
|
|
1,059.7 |
|
|
|
1,077.4 |
|
Stockholders’ Equity |
|
|
3,554.4 |
|
|
|
3,233.2 |
|
Total Liabilities and Stockholders’ Equity |
|
$ |
8,444.8 |
|
|
$ |
7,996.5 |
|
|
||||||||
Condensed Consolidated Statements of Cash Flow (Unaudited) |
||||||||
|
|
Six Months Ended |
|
|||||
(Dollars in millions) |
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
Net Income |
|
$ |
391.5 |
|
|
$ |
439.0 |
|
|
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
107.3 |
|
|
|
110.3 |
|
Change in fair value of business acquisition liabilities |
|
|
- |
|
|
|
(57.0 |
) |
Deferred income taxes |
|
|
2.4 |
|
|
|
20.9 |
|
Non-cash compensation |
|
|
17.9 |
|
|
|
16.8 |
|
Other |
|
|
(6.4 |
) |
|
|
2.9 |
|
Subtotal |
|
|
512.7 |
|
|
|
532.9 |
|
|
|
|
|
|
|
|
||
Changes in assets and liabilities: |
|
|
|
|
|
|
||
Accounts receivable |
|
|
(7.5 |
) |
|
|
12.5 |
|
Inventories |
|
|
(133.0 |
) |
|
|
(60.3 |
) |
Other current assets |
|
|
10.0 |
|
|
|
2.6 |
|
Accounts payable and accrued expenses |
|
|
(62.1 |
) |
|
|
(134.5 |
) |
Income taxes payable |
|
|
2.0 |
|
|
|
0.1 |
|
Other |
|
|
(11.7 |
) |
|
|
(9.0 |
) |
Net cash from operating activities |
|
|
310.4 |
|
|
|
344.3 |
|
|
|
|
|
|
|
|
||
Capital expenditures |
|
|
(38.8 |
) |
|
|
(43.3 |
) |
Other |
|
|
(1.0 |
) |
|
|
(4.3 |
) |
Net cash (used in) investing activities |
|
|
(39.8 |
) |
|
|
(47.6 |
) |
|
|
|
|
|
|
|
||
Net change in long-term debt |
|
|
499.8 |
|
|
|
(100.0 |
) |
Net change in short-term debt |
|
|
(249.5 |
) |
|
|
(118.4 |
) |
Payment of cash dividends |
|
|
(127.4 |
) |
|
|
(123.8 |
) |
Proceeds from stock option exercises |
|
|
16.9 |
|
|
|
12.5 |
|
Deferred financing and other |
|
|
(7.6 |
) |
|
|
(0.1 |
) |
Net cash (used in) financing activities |
|
|
132.2 |
|
|
|
(329.8 |
) |
|
|
|
|
|
|
|
||
F/X impact on cash |
|
|
(3.7 |
) |
|
|
(0.2 |
) |
|
|
|
|
|
|
|
||
Net change in cash and cash equivalents |
|
$ |
399.1 |
|
|
$ |
(33.3 |
) |
2022 and 2021 Product |
||||||||||||
|
Three Months Ended |
|
|
Percent |
|
|||||||
|
|
|
|
|
|
|
Change |
|
||||
Household Products |
$ |
572.8 |
|
|
$ |
523.0 |
|
|
|
9.5 |
% |
|
Personal Care Products |
|
431.9 |
|
|
|
436.7 |
|
|
|
-1.1 |
% |
|
Consumer Domestic |
$ |
1,004.7 |
|
|
$ |
959.7 |
|
|
|
4.7 |
% |
|
|
|
230.5 |
|
|
|
226.8 |
|
|
|
1.6 |
% |
|
Total Consumer |
$ |
1,235.2 |
|
|
$ |
1,186.5 |
|
|
|
4.1 |
% |
|
Specialty Products Division |
|
89.9 |
|
|
|
84.6 |
|
|
|
6.3 |
% |
|
Total |
$ |
1,325.1 |
|
|
$ |
1,271.1 |
|
|
|
4.2 |
% |
|
|
|
|
|
|
|
|
|
|
||||
|
Six Months Ended |
|
|
Percent |
|
|||||||
|
|
|
|
|
|
|
Change |
|
||||
Household Products |
$ |
1,093.3 |
|
|
$ |
1,018.2 |
|
|
|
7.4 |
% |
|
Personal Care Products |
|
906.5 |
|
|
|
883.9 |
|
|
|
2.6 |
% |
|
Consumer Domestic |
$ |
1,999.8 |
|
|
$ |
1,902.1 |
|
|
|
5.1 |
% |
|
|
|
445.1 |
|
|
|
443.2 |
|
|
|
0.4 |
% |
|
Total Consumer |
$ |
2,444.9 |
|
|
$ |
2,345.3 |
|
|
|
4.2 |
% |
|
Specialty Products Division |
|
177.4 |
|
|
|
164.7 |
|
|
|
7.7 |
% |
|
Total |
$ |
2,622.3 |
|
|
$ |
2,510.0 |
|
|
|
4.5 |
% |
Non-GAAP Measures:
The following discussion addresses the non-GAAP measures used in this press release and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures. These non-GAAP financial measures should not be considered in isolation from or as a substitute for the comparable GAAP measures. The following non-GAAP measures may not be the same as similar measures provided by other companies due to differences in methods of calculation and items and events being excluded.
Organic Sales Growth:
This press release provides information regarding organic sales growth, namely net sales growth excluding the effect of acquisitions, divestitures and foreign exchange rate changes. Management believes that the presentation of organic sales growth is useful to investors because it enables them to assess, on a consistent basis, sales trends related to products that were marketed by the Company during the entirety of relevant periods, excluding the impact of acquisitions, divestitures, and foreign exchange rate changes that are out of the control of, and do not reflect the performance of the Company and management.
Adjusted Selling, General, and Administrative Expense (SG&A):
This press release also presents adjusted SG&A, namely, SG&A calculated in accordance with GAAP, as adjusted to exclude significant one-time items that are not indicative of the Company’s period-to-period performance. We believe that this metric provides investors a useful perspective of underlying business trends and results and provides useful supplemental information regarding our year over year SG&A expense.
Adjusted Income from Operations:
This press release also presents adjusted income from operations, namely income from operations calculated in accordance with GAAP, as adjusted to exclude significant one-time items that are not indicative of the Company’s period-to-period performance. We believe that this metric provides investors a useful perspective of underlying business trends and results and provides useful supplemental information regarding our year over year income from operations.
Adjusted EPS:
This press release also presents adjusted earnings per share, namely, EPS calculated in accordance with GAAP, as adjusted to exclude significant one-time items that are not indicative of the Company’s period-to-period performance. We believe that this metric provides investors a useful perspective of underlying business trends and results and provides useful supplemental information regarding our year over year EPS growth.
|
|||||||||
Organic Sales |
|||||||||
|
Three Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
Total |
|
Worldwide |
|
Consumer |
|
Consumer |
|
Specialty |
|
Company |
|
Consumer |
|
Domestic |
|
International |
|
Products |
Reported Sales Growth |
|
|
|
|
|
|
|
|
|
Less: |
|
|
|
|
|
|
|
|
|
Acquisitions |
|
|
|
|
|
|
|
|
|
Add: |
|
|
|
|
|
|
|
|
|
FX / Other |
|
|
|
|
|
|
|
|
|
Divestitures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Organic Sales Growth |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
||||||||
|
|
|
|
|
|
|
|
|
|
|
Total |
|
Worldwide |
|
Consumer |
|
Consumer |
|
Specialty |
|
Company |
|
Consumer |
|
Domestic |
|
International |
|
Products |
Reported Sales Growth |
|
|
|
|
|
|
|
|
|
Less: |
|
|
|
|
|
|
|
|
|
Acquisitions |
|
|
|
|
|
|
|
|
|
Add: |
|
|
|
|
|
|
|
|
|
FX / Other |
|
|
|
|
|
|
|
|
|
Divestitures |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Organic Sales Growth |
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
Reconciliation of GAAP Measures to Non-GAAP Measures (Unaudited) |
||||||||||||||||||||
(Dollars in millions, except per share data) |
||||||||||||||||||||
|
For the quarter ended
|
|
|
For the quarter ended
|
|
|
Change |
|||||||||||||
|
|
|
|
% of NS |
|
|
|
|
|
% of NS |
|
|
|
|
|
|||||
Adjusted SG&A Reconciliation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
SG&A - Reported |
$ |
180.8 |
|
|
|
13.6 |
% |
|
$ |
136.5 |
|
|
|
10.7 |
% |
|
|
290 |
|
bps |
Flawless Earn-Out Adjustment |
|
- |
|
|
|
0.0 |
% |
|
|
38.0 |
|
|
|
3.0 |
% |
|
|
-300 |
|
bps |
SG&A - Adjusted (non-GAAP) |
$ |
180.8 |
|
|
|
13.6 |
% |
|
$ |
174.5 |
|
|
|
13.7 |
% |
|
|
-10 |
|
bps |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
For the quarter ended
|
|
|
For the quarter ended
|
|
|
Change |
|||||||||||||
Adjusted Income From Operations |
|
|
|
% of NS |
|
|
|
|
|
% of NS |
|
|
|
|
|
|||||
Income From Operations - Reported |
$ |
261.6 |
|
|
|
19.8 |
% |
|
$ |
298.7 |
|
|
|
23.5 |
% |
|
|
-370 |
|
bps |
Flawless Earn-Out Adjustment |
|
- |
|
|
|
0.0 |
% |
|
|
-38.0 |
|
|
|
-3.0 |
% |
|
|
300 |
|
bps |
Income From Operations - Adjusted (non-GAAP) |
$ |
261.6 |
|
|
|
19.8 |
% |
|
$ |
260.7 |
|
|
|
20.5 |
% |
|
|
-70 |
|
bps |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
For the quarter ended
|
|
|
For the quarter ended
|
|
|
Change |
|||||||||||||
Adjusted Diluted Earnings Per Share Reconciliation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Diluted Earnings Per Share - Reported |
$ |
0.76 |
|
|
|
|
|
$ |
0.87 |
|
|
|
|
|
|
-12.6 |
% |
|
||
Flawless Earn-Out Adjustment |
|
- |
|
|
|
|
|
|
-0.11 |
|
|
|
|
|
|
|
|
|||
Diluted Earnings Per Share - Adjusted (non-GAAP) |
$ |
0.76 |
|
|
|
|
|
$ |
0.76 |
|
|
|
|
|
|
0.0 |
% |
|
Reported and Organic Forecasted Sales Reconciliation |
|||
|
|
|
|
|
For the Quarter |
|
For the Year |
|
Ended |
|
Ended |
|
|
|
|
Reported Sales Growth |
|
|
|
Less: Acquisition |
- |
|
- |
Add: FX / Other |
|
|
|
|
|
|
|
Organic Sales Growth |
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220729005096/en/
Chief Financial Officer
609-806-1200
Source:
FAQ
What were Church & Dwight's Q2 2022 net sales?
How much did organic sales grow for Church & Dwight in Q2 2022?
What is the expected EPS for Church & Dwight in 2022?
How did Church & Dwight's domestic and international sales perform in Q2 2022?